These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31120519)

  • 21. Safety-Net Primary Care and Endocrinology Clinicians' Knowledge and Perspectives on Screening for Nonalcoholic Fatty Liver Disease: A Mixed-Methods Evaluation.
    Fantasia KL; Austad K; Mohanty A; Long MT; Walkey A; Drainoni ML
    Endocr Pract; 2024 Mar; 30(3):270-277. PubMed ID: 38184239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease.
    Kanwal F; Neuschwander-Tetri BA; Loomba R; Rinella ME
    Hepatology; 2024 May; 79(5):1212-1219. PubMed ID: 38445559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary care provider perceptions of enablers and barriers to following guideline-recommended laboratory tests to confirm chronic kidney disease: a qualitative descriptive study.
    Nash DM; Garg AX; Brimble KS; Markle-Reid M
    BMC Fam Pract; 2018 Dec; 19(1):192. PubMed ID: 30526501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From expected to actual barriers and facilitators when implementing a new screening tool: A qualitative study applying the Theoretical Domains Framework.
    Petersen HV; Sivertsen DM; Jørgensen LM; Petersen J; Kirk JW
    J Clin Nurs; 2023 Jun; 32(11-12):2867-2879. PubMed ID: 35739640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Watanabe S; Hashimoto E; Ikejima K; Uto H; Ono M; Sumida Y; Seike M; Takei Y; Takehara T; Tokushige K; Nakajima A; Yoneda M; Saibara T; Shiota G; Sakaida I; Nakamuta M; Mizuta T; Tsubouchi H; Sugano K; Shimosegawa T; ;
    J Gastroenterol; 2015 Apr; 50(4):364-77. PubMed ID: 25708290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using the theoretical domains framework to identify barriers and enablers to pediatric asthma management in primary care settings.
    Yamada J; Potestio ML; Cave AJ; Sharpe H; Johnson DW; Patey AM; Presseau J; Grimshaw JM
    J Asthma; 2018 Nov; 55(11):1223-1236. PubMed ID: 29261346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonalcoholic Fatty Liver Disease: An Important Consideration for Primary Care Providers in Hawai'i.
    Pattison RJ; Esteban JP; Sempokuya T; Kewcharoen J; Kalathil S; Kuwada SK
    Hawaii J Health Soc Welf; 2020 Jun; 79(6):180-186. PubMed ID: 32524096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of nonalcoholic fatty liver disease in the Middle East.
    Sanai FM; Abaalkhail F; Hasan F; Farooqi MH; Nahdi NA; Younossi ZM
    World J Gastroenterol; 2020 Jul; 26(25):3528-3541. PubMed ID: 32742124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing Making Every Contact Count (MECC) interventions: A strategic behavioral analysis.
    Haighton C; Newbury-Birch D; Durlik C; Sallis A; Chadborn T; Porter L; Harling M; Rodrigues A
    Health Psychol; 2021 Dec; 40(12):960-973. PubMed ID: 34928634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Barriers and facilitators to shared decision making in child and youth mental health: clinician perspectives using the Theoretical Domains Framework.
    Hayes D; Edbrooke-Childs J; Town R; Wolpert M; Midgley N
    Eur Child Adolesc Psychiatry; 2019 May; 28(5):655-666. PubMed ID: 30229306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Similarities and differences between pediatric and adult nonalcoholic fatty liver disease.
    Crespo M; Lappe S; Feldstein AE; Alkhouri N
    Metabolism; 2016 Aug; 65(8):1161-71. PubMed ID: 26961580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
    Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 'It's difficult, I think it's complicated': Health care professionals' barriers and enablers to providing opportunistic behaviour change interventions during routine medical consultations.
    Keyworth C; Epton T; Goldthorpe J; Calam R; Armitage CJ
    Br J Health Psychol; 2019 Sep; 24(3):571-592. PubMed ID: 30977291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding Primary Care Physician Perspectives on the Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: A Qualitative Study.
    Heredia NI; John JC; Singh S; Hwang JP; Strong LL; Balakrishnan M; McNeill LH
    Inquiry; 2024; 61():469580241241272. PubMed ID: 38529894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reducing catheter-associated urinary tract infections: a systematic review of barriers and facilitators and strategic behavioural analysis of interventions.
    Atkins L; Sallis A; Chadborn T; Shaw K; Schneider A; Hopkins S; Bunten A; Michie S; Lorencatto F
    Implement Sci; 2020 Jul; 15(1):44. PubMed ID: 32624002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementation of pregnancy weight management and obesity guidelines: a meta-synthesis of healthcare professionals' barriers and facilitators using the Theoretical Domains Framework.
    Heslehurst N; Newham J; Maniatopoulos G; Fleetwood C; Robalino S; Rankin J
    Obes Rev; 2014 Jun; 15(6):462-86. PubMed ID: 24629076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice.
    Zhou JH; Cai JJ; She ZG; Li HL
    World J Gastroenterol; 2019 Mar; 25(11):1307-1326. PubMed ID: 30918425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delivering an iterative Communication Partner Training programme to multidisciplinary healthcare professionals: A pilot implementation study and process evaluation.
    Shrubsole K; Lin TJ; Burton C; Scott J; Finch E
    Int J Lang Commun Disord; 2021 May; 56(3):620-636. PubMed ID: 33818902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonalcoholic fatty liver disease: a systematic review.
    Rinella ME
    JAMA; 2015 Jun; 313(22):2263-73. PubMed ID: 26057287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation.
    Younossi ZM
    Liver Transpl; 2018 Feb; 24(2):166-170. PubMed ID: 29272073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.